Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS 0.00%·Rev n/aQ1 26EPS +58.33%·Rev n/aQ4 25EPS -64.61%·Rev n/aQ3 25EPS +23.08%·Rev n/a⚠ consensus missing

Evolus, Inc. EOLS

Nareg Sagherian — Vice President and Head of Global Investor Relations in Corporate Communications

David Moatazedi — President and Chief Executive Officer

Rui Avelar — Chief Medical Officer and Head of R&D

Tatjana Mitchell — Chief Financial Officer

+19.9%1d on move date3d+22.5%5d+31.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EOLS calls or request research access.

More EOLS calls Browse calls Request research access